Search

Search Results

• 

  Factors associated with loss to follow-up among people with tuberculosis in the country of Georgia: a cohort study

  Natalia Adamashvili, Kristina Akopyan, Nestani Tukvadze, Kostyantyn Dumchev, Yuliia Sereda, Irma Khonelidze, Giorgi Kuchukhidze

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1705

  2596

  PDF: 736

  Supplementary: 185
• 

  Effectiveness and safety of delamanid- or bedaquiline-containing regimens among children and adolescents with multidrug resistant or extensively drug resistant tuberculosis: A nationwide study from Belarus, 2015-19

  Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1646

  3360

  PDF: 1531

  Supplementary: 290
• 

  Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019-2020

  Teona Avaliani, Yuliia Sereda, Hayk Davtyan, Nestani Tukvadze, Tamar Togonidze, Nana Kiria, Olga Denisiuk, Ogtay Gozalov, Sevim Ahmedov, Arax Hovhannesyan

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1679

  2920

  PDF: 1355

  Supplementary: 207
• 

  Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

  Anastasiia Russkikh, Oleksandr Korotych, Yuliia Sereda, Anastasia Samoilova, Jay Achar, Askar Yedilbayev, Masoud Dara, Irina Vasilyeva

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1678

  1973

  PDF: 1186
• 

  Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

  Saulius Diktanas, Oleksandr Korotych, Yuliia Sereda, Ogtay Gozalov, Olga Rubcova, Jay Achar

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1675

  1654

  PDF: 871
• 

  Do catastrophic costs impact treatment outcomes in people with rifampicin-resistant tuberculosis in the Republic of Moldova?

  Valeriu Plesca, Ana Ciobanu, Yuliia Sereda, Andrei Dadu

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1650

  1784

  PDF: 779

  Supplementary: 188
• 

  Incidence rate and time to serious adverse events among rifampicin resistant tuberculosis patients in Georgia treated with new and repurposed anti-tuberculosis drugs, 2016-2018

  Mariana Buziashvili, Hayk Davtyan, Yuliia Sereda, Olga Denisiuk, Ogtay Gozalov, Nino Lomtadze, Arax Hovhannesyan

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1649

  2265

  PDF: 1060

  Supplementary: 236
• 

  Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18

  Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina

  2021-01-14

  https://doi.org/10.4081/monaldi.2021.1647

  2368

  PDF: 1223

  Supplementary: 286